SWOT ANALYSIS OF BULGARIAN LEGISLATION IN WHOLESALE WITH MEDICINAL PRODUCTS
Vasil Madjarov1, Valentina Petkova2, Stanislav Gueurguiev1, Kalina Andreevska1, Milen Dimitrov2
Distribution of medicinal products is an important component of drug supply process and serves as the link between manufacturers and distributors of drugs to patients. It serves as a buffer between the medication needs of the population and their satisfaction regardless of what administrative subordination are the individual elements of complex drug resupply process in a country. The main document developed by WHO and which regulates the requirements for the distribution of drug products is Good distribution practice (GDP) with the primary task to ensure that manufactured and marketed drug
products for distribution to patients with adequate quality. This quality level must be maintained through the distribution network such that the permitted to use drugs to circulate the population with no change in their properties. To maintain the quality of the drugs and the quality of services offered, the wholesalers must comply with the principles and guidelines of the GDP.